Isolators and RABS systems play a central role in sterile manufacturing environments. Their design is based on strict physical separation between the product and the operator, which imposes high requirements in terms of biodécontamination.
In this context, VH₂O₂ technology represents a suitable approach for confined volumes, complex geometries and continuous production constraints.
Isolators and RABS: highly constrained environments
Isolators and RABS are characterised by reduced volumes and complex internal structures. Mechanical interfaces, gloves, viewing windows and transfer systems multiply the number of surfaces to be treated. Any poorly exposed area can become a critical point for microbiological control.
These environments also impose strict constraints on material compatibility and process stability. Biodécontamination must be effective without altering sensitive components or disrupting equipment integrated into the system.
Challenges of biodécontamination in isolators and RABS
Biodécontamination of isolators and RABS raises specific challenges related to biocide diffusion and equipment protection.
Biocide diffusion in confined volumes
In confined volumes, achieving homogeneous biocide diffusion is a major challenge. Partially obstructed areas, corners and internal interfaces can limit direct access to surfaces. A biodécontamination technology must therefore ensure complete volume occupation in order to treat all exposed and hard-to-reach surfaces.
Protection of equipment and sensitive interfaces
Isolators and RABS integrate numerous sensitive components such as seals, gloves, sensors and viewing windows. The presence of condensation or liquid deposits can affect these elements and compromise their service life. Biodécontamination must preserve material integrity while maintaining high microbiological efficacy.
Contribution of VH₂O₂ dry-fog technology in these environments
VH₂O₂ dry-fog technology addresses the specific constraints of isolators and RABS through fine and controlled biocide diffusion. This approach relies on ultrafine atomisation at ambient temperature, well suited to confined volumes.
Homogeneous diffusion without dependence on airflows
The dry-fog process allows hydrogen peroxide mist to naturally occupy the internal space of the isolator or RABS. Diffusion does not rely on artificial airflows or ventilation-induced turbulence.
This promotes homogeneous surface coverage, including in geometrically complex areas.
Absence of condensation and material compatibility
The absence of visible condensation is a key advantage in isolators and RABS. Dry mist limits surface wetting and reduces the risk of material degradation. This characteristic contributes to preserving seals, gloves and electronic components integrated into sterile production systems.
Integration of VH₂O₂ into isolator and RABS cycles
Integrating VH₂O₂ into isolator and RABS biodécontamination cycles aims to achieve high efficacy while minimising impact on equipment availability. Cycles remain compatible with strict production constraints.
Dry-fog technology enables rapid degassing after the exposure phase. This feature allows faster return to service of isolators and RABS, supporting production schedules and continuity of operations in sterile environments.
Solidfog’s approach to biodécontamination of isolators and RABS
Biodécontamination of confined environments requires both adapted technology and a controlled approach. Solidfog positions VH₂O₂ dry-fog technology within this framework, in line with GMP environment requirements.
A technology suited to confined environments
Solidfog relies on precise control of atomisation to ensure homogeneous VH₂O₂ diffusion within isolators and RABS. This approach enables effective treatment of small and complex volumes without dependence on internal airflows.
Diffusion stability supports consistent and reproducible microbiological performance.
Consistent integration in GMP environments
Solidfog VH₂O₂ technology integrates into GMP validation strategies. Cycle reproducibility and parameter control facilitate process documentation and qualification.
This consistency is a key factor for sites operating under stringent regulatory requirements.
Discuss an isolator or RABS project with Solidfog
Biodécontamination of isolators and RABS is closely linked to equipment configuration and sterile production requirements. Volume, interfaces and operational constraints influence process selection and technical parameters.
Solidfog supports pharmaceutical and biotechnological sites during this scoping phase to define a VH₂O₂ approach that is coherent, controlled and compatible with GMP requirements.